Skip to main content

Understanding organ dysfunction in Ebola virus disease

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Leroy EM, Gonzalez J-P, Baize S (2011) Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect 17:964–976. doi:10.1111/j.1469-0691.2011.03535.x

    CAS  Article  Google Scholar 

  2. Feldmann H, Geisbert TW (2011) Ebola haemorrhagic fever. Lancet 377:849–862. doi:10.1016/S0140-6736(10)60667-8

    PubMed Central  PubMed  Article  Google Scholar 

  3. WHO Ebola Response Team (2014) Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med. 371:1481–1495. doi:10.1056/NEJMoa1411100

    Google Scholar 

  4. Cohen J (2002) The immunopathogenesis of sepsis. Nature 420:885–891

    CAS  PubMed  Article  Google Scholar 

  5. Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369:840–851. doi:10.1056/NEJMra1208623

    CAS  PubMed  Article  Google Scholar 

  6. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Intensive Care Med 39(2):165–228. doi:10.1007/s00134-012-2769-8

    CAS  PubMed  Article  Google Scholar 

  7. McElroy AK, Erickson BR, Flietstra TD, Rollin PE, Nichol ST, Towner JS, Spiropolou CF (2014) Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis 210(4):558–566. doi:10.1093/infdis/jiu088

    CAS  PubMed  Article  Google Scholar 

  8. Bente D, Gren J, Strong JE, Feldmann H (2009) Disease modeling for Ebola and Marburg viruses. Dis Model Mech 2:12–17. doi:10.1242/dmm.000471

    PubMed Central  PubMed  Article  Google Scholar 

  9. Geisbert TW, Jahrling PB (2004) Exotic emerging viral diseases: progress and challenges. Nature Med 10(Suppl 12):S110–121. doi:10.1038/nm1142

    CAS  PubMed  Article  Google Scholar 

  10. Mahanty S, Bray M (2004) Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 4(8):487–498

    CAS  PubMed  Article  Google Scholar 

  11. Mohamadzadeh M, Chen L, Schmaljohn AL (2007) How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 7:556–567. doi:10.1038/nri2098

    CAS  PubMed  Article  Google Scholar 

  12. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, Hensley LE (2003) Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 163:2371–2382

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  13. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB, Zaki SR, Swanepoel R, Ansari AA, Peters CJ (1999) Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 179(Suppl 1):S188–191. doi:10.1086/514283

    CAS  PubMed  Article  Google Scholar 

  14. Hensley LE, Young HA, Jahrling PB, Geisbert TW (2002) Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 80:169–179. doi:10.1016/s0165-2478(01)00327-3

    CAS  Google Scholar 

  15. Reed DS, Hensley LE, Geisbert JB, Jahrling PB, Geisbert TW (2004) Depletion of peripheral blood T lymphocytes and NK cells during the course of ebolahemorrhagic fever in cynomolgus macaques. Viral Immunol 17:390–400. doi:10.1089/vim.2004.17.390

    CAS  PubMed  Article  Google Scholar 

  16. Leblebicioglu H, Bodur H, Dokuzoguz B, Elaldi N, Guner R, Koksal I, Kurt H, Senturk GC (2012) Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis 12:805–811. doi:10.1089/vbz.2011.0896

    PubMed  Article  Google Scholar 

  17. Rollin PE, Bausch DG, Sanchez A (2007) Blood chemistry measurements and D-dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola Virus. J Infect Dis 196(Suppl 2):S364–371

    CAS  PubMed  Article  Google Scholar 

  18. Mupere E, Kaducu OF, Yoti Z (2001) Ebola haemorrhagic fever among hospitalised children and adolescents in nothern Uganda : epidemiologic and clinical observations. Afr Hlth Sci 1(2): 60–65. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2141551/

  19. Goodman JL (2014) Studying “Secret Serums”—toward safe, effective Ebola treatments. N Engl J Med 371:108–1089. doi:10.1056/NEJMp1409817

    Article  Google Scholar 

  20. Fowler RA, Fletcher T, Fischer WA, Lamontagne F, Jacob S, Brett-Major D et al (2014) Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med 190(7):733–737

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

Drs Fletcher and Fowler both provide assistance to Ebola Treatment Centres in West Africa, supported by the World Health Organization. Dr Fletcher receives support from the Wellcome Trust and from the Ministry of Defence. Dr Fowler is a clinician scientist of the Heart and Stroke Foundation (Ontario, Canada). Dr Beeching is partially supported by a National Institute of Health Research grant to the Health Protection Research Unit in Emerging and Zoonotic Infections, a collaboration between the University of Liverpool, Liverpool School of Tropical Medicine and Public Health England. Views expressed are those of the authors.

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicholas J. Beeching.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fletcher, T.E., Fowler, R.A. & Beeching, N.J. Understanding organ dysfunction in Ebola virus disease. Intensive Care Med 40, 1936–1939 (2014). https://doi.org/10.1007/s00134-014-3515-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-014-3515-1

Keywords

  • Disseminate Intravascular Coagulation
  • Capillary Leak Syndrome
  • Poor Prognostic Sign
  • Inadequate Oral Intake
  • Haemorrhagic Manifestation